Zdrowie i gospodarka · 21/11/2016
Substantiation for Structure/Function Claims Made in Infant Formula Labels and Labeling: Draft Guidance for Industry; Reopening of the Comment Period
The Food and Drug Administration (FDA or we) is reopening the comment period for the notice, published in the Federal Register of September 9, 2016 (81 FR 62509), announcing the availability of the draft guidance for industry entitled "Substantiation for Structure/ Function Claims Made in Infant Formula Labels and Labeling." We are reopening the comment period in response to a request for an extension to allow interested persons additional time to submit comments.